Associations	O
of	O
gender	O
and	O
a	O
proxy	O
of	O
female	O
menopausal	B:C1513126
status	I:C1513126
with	O
histological	O
features	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

Associations	O
of	O
gender	O
and	O
a	O
proxy	O
of	O
female	O
menopausal	O
status	I:C1513126
with	O
histological	O
features	O
of	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

Gender	O
and	O
menopause	B:C0025320
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
(	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
)	O
by	O
influencing	O
host	O
responses	O
to	O
injury	O
.	O

Gender	O
and	O
menopause	O
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
(	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
)	O
by	O
influencing	O
host	O
responses	O
to	O
injury	O
.	O

Gender	O
and	O
menopause	O
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
(	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
)	O
by	O
influencing	O
host	O
responses	O
to	O
injury	O
.	O

Gender	O
and	O
menopause	O
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
(	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
)	O
by	O
influencing	O
host	O
responses	B:C1704632
to	O
injury	O
.	O

Gender	O
and	O
menopause	O
may	O
contribute	O
to	O
type	O
and	O
severity	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
(	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
)	O
by	O
influencing	O
host	O
responses	O
to	O
injury	B:C3263723
.	O

The	O
aim	O
of	O
this	O
study	B:C2603343
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	O
]	O
with	O
histological	O
features	O
of	O
liver	O
injury	I:C0160390
in	O
212	O
adults	O
enrolled	O
in	O
the	O
Drug	O
-	I:C0860207
Induced	I:C0860207
Liver	I:C0860207
Injury	I:C0860207
Network	O
(	O
DILIN	O
)	O
registry	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	B:C0025320
]	O
with	O
histological	O
features	O
of	O
liver	O
injury	I:C0160390
in	O
212	O
adults	O
enrolled	O
in	O
the	O
Drug	O
-	I:C0860207
Induced	I:C0860207
Liver	I:C0860207
Injury	I:C0860207
Network	O
(	O
DILIN	O
)	O
registry	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	O
]	O
with	O
histological	O
features	O
of	O
liver	B:C0160390
injury	I:C0160390
in	O
212	O
adults	O
enrolled	O
in	O
the	O
Drug	O
-	I:C0860207
Induced	I:C0860207
Liver	I:C0860207
Injury	I:C0860207
Network	O
(	O
DILIN	O
)	O
registry	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	O
]	O
with	O
histological	O
features	O
of	O
liver	O
injury	I:C0160390
in	O
212	O
adults	O
enrolled	O
in	O
the	O
Drug	B:C0860207
-	I:C0860207
Induced	I:C0860207
Liver	I:C0860207
Injury	I:C0860207
Network	O
(	O
DILIN	O
)	O
registry	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
associations	O
of	O
gender	O
and	O
female	O
age	O
50	O
[	O
a	O
proxy	O
of	O
menopause	O
]	O
with	O
histological	O
features	O
of	O
liver	O
injury	I:C0160390
in	O
212	O
adults	O
enrolled	O
in	O
the	O
Drug	O
-	I:C0860207
Induced	I:C0860207
Liver	I:C0860207
Injury	I:C0860207
Network	O
(	O
DILIN	O
)	O
registry	B:C0034975
.	O

All	O
participants	B:C0679646
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	O
'	O
,	O
a	O
liver	O
biopsy	I:C0193388
within	O
30	O
days	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
onset	O
,	O
and	O
no	O
prior	O
chronic	O
liver	I:C0341439
disease	I:C0341439
.	O

All	O
participants	O
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	B:C0332148
'	O
,	O
a	O
liver	O
biopsy	I:C0193388
within	O
30	O
days	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
onset	O
,	O
and	O
no	O
prior	O
chronic	O
liver	I:C0341439
disease	I:C0341439
.	O

All	O
participants	O
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	O
'	O
,	O
a	O
liver	B:C0193388
biopsy	I:C0193388
within	O
30	O
days	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
onset	O
,	O
and	O
no	O
prior	O
chronic	O
liver	I:C0341439
disease	I:C0341439
.	O

All	O
participants	O
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	O
'	O
,	O
a	O
liver	O
biopsy	I:C0193388
within	O
30	O
days	O
of	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
onset	O
,	O
and	O
no	O
prior	O
chronic	O
liver	I:C0341439
disease	I:C0341439
.	O

All	O
participants	O
had	O
a	O
causality	O
score	O
of	O
at	O
least	O
'	O
probable	O
'	O
,	O
a	O
liver	O
biopsy	I:C0193388
within	O
30	O
days	O
of	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
onset	O
,	O
and	O
no	O
prior	O
chronic	B:C0341439
liver	I:C0341439
disease	I:C0341439
.	O

Biochemical	O
and	O
histological	O
injury	B:C3263723
types	O
were	O
classified	O
as	O
hepatocellular	O
or	O
cholestatic	O
/	I:C1737228
mixed	I:C1737228
injury	I:C1737228
.	O

Biochemical	O
and	O
histological	O
injury	O
types	O
were	O
classified	O
as	O
hepatocellular	B:C0151763
or	O
cholestatic	O
/	I:C1737228
mixed	I:C1737228
injury	I:C1737228
.	O

Biochemical	O
and	O
histological	O
injury	O
types	O
were	O
classified	O
as	O
hepatocellular	O
or	O
cholestatic	B:C1737228
/	I:C1737228
mixed	I:C1737228
injury	I:C1737228
.	O

The	O
cohort	B:C0599755
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	O
:	O
men	O
(	O
41.0	O
%	O
)	O
,	O
women	O
<	O
50	O
years	O
(	O
27.4	O
%	O
)	O
and	O
women	O
≥	O
50	O
years	O
of	O
age	O
(	O
31.6	O
%	O
)	O
.	O

The	O
cohort	O
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	B:C0683312
:	O
men	O
(	O
41.0	O
%	O
)	O
,	O
women	O
<	O
50	O
years	O
(	O
27.4	O
%	O
)	O
and	O
women	O
≥	O
50	O
years	O
of	O
age	O
(	O
31.6	O
%	O
)	O
.	O

The	O
cohort	O
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	O
:	O
men	B:C0025266
(	O
41.0	O
%	O
)	O
,	O
women	O
<	O
50	O
years	O
(	O
27.4	O
%	O
)	O
and	O
women	O
≥	O
50	O
years	O
of	O
age	O
(	O
31.6	O
%	O
)	O
.	O

The	O
cohort	O
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	O
:	O
men	O
(	O
41.0	O
%	O
)	O
,	O
women	B:C0043210
<	O
50	O
years	O
(	O
27.4	O
%	O
)	O
and	O
women	O
≥	O
50	O
years	O
of	O
age	O
(	O
31.6	O
%	O
)	O
.	O

The	O
cohort	O
was	O
divided	O
into	O
three	O
gender	O
/	O
age	O
categories	O
:	O
men	O
(	O
41.0	O
%	O
)	O
,	O
women	O
<	O
50	O
years	O
(	O
27.4	O
%	O
)	O
and	O
women	B:C0043210
≥	O
50	O
years	O
of	O
age	O
(	O
31.6	O
%	O
)	O
.	O

Interaction	O
of	O
gender	O
and	O
age	O
category	B:C0683312
(	O
≥50	O
or	O
not	O
)	O
was	O
assessed	O
.	O

Hepatocellular	B:C0151763
injury	I:C0151763
was	O
more	O
prevalent	O
in	O
women	O
<	O
50	O
years	O
vs.	O
others	O
(	O
P=.002	O
)	O
.	O

Hepatocellular	O
injury	I:C0151763
was	O
more	O
prevalent	O
in	O
women	B:C0043210
<	O
50	O
years	O
vs.	O
others	O
(	O
P=.002	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	B:C3263723
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	B:C0005680
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	B:C0332149
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	B:C0001811
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	B:C0019158
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	B:C0005558
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	B:C0043210
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	B:C0025266
and	O
women	O
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

After	O
adjusting	O
for	O
biochemical	O
injury	O
types	O
,	O
black	O
race	I:C0005680
and	O
possible	O
ageing	O
effects	O
,	O
more	O
severe	O
interface	O
hepatitis	O
was	O
noted	O
in	O
biopsies	O
of	O
women	O
<	O
50	O
years	O
compared	O
to	O
those	O
of	O
men	O
and	O
women	B:C0043210
≥	O
50	O
years	O
(	O
P=.009	O
and	O
P=.055	O
respectively	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	B:C0025266
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	B:C0005558
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	B:C0043210
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	B:C0391861
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	B:C3269241
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	B:C0227525
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	B:C0035863
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	B:C0302583
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	B:C1514241
hepatocytes	O
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	B:C0227525
and	O
histological	O
cholestasis	O
(	O
P<.05	O
)	O
.	O

Compared	O
to	O
those	O
of	O
men	O
,	O
biopsies	O
of	O
women	O
showed	O
greater	O
plasma	O
cell	I:C0391861
infiltration	I:C0391861
,	O
hepatocyte	O
apoptosis	I:C3269241
,	O
hepatocyte	O
rosettes	O
and	O
lobular	O
disarray	O
but	O
less	O
iron	O
-	O
positive	O
hepatocytes	O
and	O
histological	O
cholestasis	B:C0008370
(	O
P<.05	O
)	O
.	O

These	O
associations	O
persisted	O
after	O
excluding	O
cases	O
of	O
amoxicillin	B:C0054066
/	I:C0054066
clavulanic	I:C0054066
acid	I:C0054066
,	O
anabolic	O
steroids	I:C0002744
or	O
nitrofurantoin	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
which	O
showed	O
gender	O
-	O
specific	O
distributions	O
.	O

These	O
associations	O
persisted	O
after	O
excluding	O
cases	O
of	O
amoxicillin	O
/	I:C0054066
clavulanic	I:C0054066
acid	I:C0054066
,	O
anabolic	B:C0002744
steroids	I:C0002744
or	O
nitrofurantoin	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
which	O
showed	O
gender	O
-	O
specific	O
distributions	O
.	O

These	O
associations	O
persisted	O
after	O
excluding	O
cases	O
of	O
amoxicillin	O
/	I:C0054066
clavulanic	I:C0054066
acid	I:C0054066
,	O
anabolic	O
steroids	I:C0002744
or	O
nitrofurantoin	B:C0028156
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
which	O
showed	O
gender	O
-	O
specific	O
distributions	O
.	O

These	O
associations	O
persisted	O
after	O
excluding	O
cases	O
of	O
amoxicillin	O
/	I:C0054066
clavulanic	I:C0054066
acid	I:C0054066
,	O
anabolic	O
steroids	I:C0002744
or	O
nitrofurantoin	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
which	O
showed	O
gender	O
-	O
specific	O
distributions	O
.	O

Gender	O
and	O
a	O
proxy	O
of	O
menopause	B:C0025320
were	O
associated	O
with	O
various	O
features	O
of	O
inflammation	O
and	O
injury	O
in	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

Gender	O
and	O
a	O
proxy	O
of	O
menopause	O
were	O
associated	O
with	O
various	O
features	O
of	O
inflammation	B:C0021368
and	O
injury	O
in	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

Gender	O
and	O
a	O
proxy	O
of	O
menopause	O
were	O
associated	O
with	O
various	O
features	O
of	O
inflammation	O
and	O
injury	B:C3263723
in	O
drug	O
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

Gender	O
and	O
a	O
proxy	O
of	O
menopause	O
were	O
associated	O
with	O
various	O
features	O
of	O
inflammation	O
and	O
injury	O
in	O
drug	B:C0860207
-	I:C0860207
induced	I:C0860207
liver	I:C0860207
injury	I:C0860207
.	O

